These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3413714)

  • 1. Thrombin inhibition with dipeptidyl argininals.
    Witting JI; Pouliott C; Catalfamo JL; Fareed J; Fenton JW
    Thromb Res; 1988 May; 50(4):461-7. PubMed ID: 3413714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fibrinogen receptor expression and serotonin release by leupeptin and antipain.
    Baldassare JJ; Bakshian S; Knipp MA; Fisher GJ
    J Biol Chem; 1985 Sep; 260(19):10531-5. PubMed ID: 2993278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.
    Sonder SA; Fenton JW
    Clin Chem; 1986 Jun; 32(6):934-7. PubMed ID: 3708816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipain or leupeptin in combination with aspirin or indomethacin synergistically inhibit human platelet activation by thrombin and trypsin.
    Ruggiero M; Lapetina EG
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():563-8. PubMed ID: 2959114
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of thrombin-induced platelet activation by leupeptin. Implications for the participation of calpain in the initiation of platelet activation.
    Brass LF; Shattil SJ
    J Biol Chem; 1988 Apr; 263(11):5210-6. PubMed ID: 2833498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of starfish oocyte maturation by leupeptin analogs, potent trypsin inhibitors.
    Sawada MT; Someno T; Hoshi M; Sawada H
    Dev Biol; 1989 Jun; 133(2):609-12. PubMed ID: 2731642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Leishmania amastigote growth by antipain and leupeptin.
    Coombs GH; Baxter J
    Ann Trop Med Parasitol; 1984 Feb; 78(1):21-4. PubMed ID: 6721611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ca2+ on the inhibition of calcium-activated neutral protease by leupeptin, antipain and epoxysuccinate derivatives.
    Suzuki K; Tsuji S; Ishiura S
    FEBS Lett; 1981 Dec; 136(1):119-22. PubMed ID: 6274695
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of hemoglobin-hydrolase activity by the thiol-protease inhibitors leupeptin and antipain in adult rat liver cells in primary culture.
    Tanaka K; Ikegaki N; Ichihara A
    Biochem Biophys Res Commun; 1979 Nov; 91(1):102-7. PubMed ID: 518610
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease-inhibitory activities of leupeptin analogues.
    Saino T; Someno T; Ishii S; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1988 Feb; 41(2):220-5. PubMed ID: 2965694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo.
    Bolli R; Cannon RO; Speir E; Goldstein RE; Epstein SE
    J Am Coll Cardiol; 1983 Oct; 2(4):671-80. PubMed ID: 6350399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanalide substrates under physiologically relevant conditions.
    Witting JI; Miller TM; Fenton JW
    Thromb Res; 1987 May; 46(4):567-74. PubMed ID: 3617013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors neither damage DNA nor interfere with DNA repair or replication in human cells.
    Borek C; Cleaver JE
    Mutat Res; 1981 Jul; 82(2):373-80. PubMed ID: 7266563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii.
    Nguyen QV; Knapp W; Humphreys RE
    Hum Immunol; 1989 Mar; 24(3):153-63. PubMed ID: 2925452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a calcium dependent protease inhibitor on platelet activation and secretion.
    Rao GH; White JG; Cox CA
    Thromb Res; 1987 Sep; 47(6):625-37. PubMed ID: 3686479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins.
    Lottenberg R; Hall JA; Fenton JW; Jackson CM
    Thromb Res; 1982 Nov; 28(3):313-32. PubMed ID: 7179220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals, new orally active stable analogues of D-Phe-Pro-Arg-H.
    Bajusz S; Barabas E; Fauszt I; Feher A; Horvath G; Juhasz A; Szabo GA; Szell E
    Semin Thromb Hemost; 1996; 22(3):243-6. PubMed ID: 8836008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and inhibition of cathepsin B and hemoglobin-hydrolase activity in murine B16 melanoma by thiol protease inhibitors.
    Nakao H; Kurita Y; Tsuboi R; Takamori K; Ogawa H
    Comp Biochem Physiol B; 1986; 85(2):435-7. PubMed ID: 3536282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
    Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.